Interleukin-4 modulates type I interferon to augment anti-tumour immunity [scRNA-Seq]
Single-cell RNA-seq · mouse · 36 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart.
- Organism
- Mus musculus (mouse)
- Samples
- 36 samples: 9 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Interleukin-4 modulates type I interferon to augment antitumor immunityScience advances · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE289723_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1224250 and SRA study SRP564167. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 36 samples.
How we read this: 9 replicated groups read from 36 sample titles; they account for 36 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8797547 B16-GFP Tumours (Day 8) mouse 1 biol rep 1 B16-GFP Tumours (Day 8)…
- GSM8797548 B16-GFP Tumours (Day 8) mouse 1 biol rep 2 B16-GFP Tumours (Day 8)…
- GSM8797549 B16-GFP Tumours (Day 8) mouse 1 biol rep 3 B16-GFP Tumours (Day 8)…
- GSM8797550 B16-GFP Tumours (Day 8) mouse 1 biol rep 4 B16-GFP Tumours (Day 8)…
- GSM8797551 B16-GFP Tumours (Day 8) mouse 2 biol rep 1 B16-GFP Tumours (Day 8)…
- GSM8797552 B16-GFP Tumours (Day 8) mouse 2 biol rep 2 B16-GFP Tumours (Day 8)…
- GSM8797553 B16-GFP Tumours (Day 8) mouse 2 biol rep 3 B16-GFP Tumours (Day 8)…
- GSM8797554 B16-GFP Tumours (Day 8) mouse 2 biol rep 4 B16-GFP Tumours (Day 8)…
- GSM8797555 B16-GFP Tumours (Day 8) mouse 3 biol rep 1 B16-GFP Tumours (Day 8)…
- GSM8797556 B16-GFP Tumours (Day 8) mouse 3 biol rep 2 B16-GFP Tumours (Day 8)…
- GSM8797557 B16-GFP Tumours (Day 8) mouse 3 biol rep 3 B16-GFP Tumours (Day 8)…
- GSM8797558 B16-GFP Tumours (Day 8) mouse 3 biol rep 4 B16-GFP Tumours (Day 8)…
- GSM8797559 B16-IFNA4 Tumours (Day 8) mouse 1 biol rep 1 B16-IFNA4 Tumours (Day …
- GSM8797560 B16-IFNA4 Tumours (Day 8) mouse 1 biol rep 2 B16-IFNA4 Tumours (Day …
- GSM8797561 B16-IFNA4 Tumours (Day 8) mouse 1 biol rep 3 B16-IFNA4 Tumours (Day …
- GSM8797562 B16-IFNA4 Tumours (Day 8) mouse 1 biol rep 4 B16-IFNA4 Tumours (Day …
- GSM8797563 B16-IFNA4 Tumours (Day 8) mouse 2 biol rep 1 B16-IFNA4 Tumours (Day …
- GSM8797564 B16-IFNA4 Tumours (Day 8) mouse 2 biol rep 2 B16-IFNA4 Tumours (Day …
- GSM8797565 B16-IFNA4 Tumours (Day 8) mouse 2 biol rep 3 B16-IFNA4 Tumours (Day …
- GSM8797566 B16-IFNA4 Tumours (Day 8) mouse 2 biol rep 4 B16-IFNA4 Tumours (Day …
- GSM8797567 B16-IFNA4 Tumours (Day 8) mouse 3 biol rep 1 B16-IFNA4 Tumours (Day …
- GSM8797568 B16-IFNA4 Tumours (Day 8) mouse 3 biol rep 2 B16-IFNA4 Tumours (Day …
- GSM8797569 B16-IFNA4 Tumours (Day 8) mouse 3 biol rep 3 B16-IFNA4 Tumours (Day …
- GSM8797570 B16-IFNA4 Tumours (Day 8) mouse 3 biol rep 4 B16-IFNA4 Tumours (Day …
- GSM8797571 B16-IFNA9 Tumours (Day 8) mouse 1 biol rep 1 B16-IFNA9 Tumours (Day …
- GSM8797572 B16-IFNA9 Tumours (Day 8) mouse 1 biol rep 2 B16-IFNA9 Tumours (Day …
- GSM8797573 B16-IFNA9 Tumours (Day 8) mouse 1 biol rep 3 B16-IFNA9 Tumours (Day …
- GSM8797574 B16-IFNA9 Tumours (Day 8) mouse 1 biol rep 4 B16-IFNA9 Tumours (Day …
- GSM8797575 B16-IFNA9 Tumours (Day 8) mouse 2 biol rep 1 B16-IFNA9 Tumours (Day …
- GSM8797576 B16-IFNA9 Tumours (Day 8) mouse 2 biol rep 2 B16-IFNA9 Tumours (Day …
- GSM8797577 B16-IFNA9 Tumours (Day 8) mouse 2 biol rep 3 B16-IFNA9 Tumours (Day …
- GSM8797578 B16-IFNA9 Tumours (Day 8) mouse 2 biol rep 4 B16-IFNA9 Tumours (Day …
- GSM8797579 B16-IFNA9 Tumours (Day 8) mouse 3 biol rep 1 B16-IFNA9 Tumours (Day …
- GSM8797580 B16-IFNA9 Tumours (Day 8) mouse 3 biol rep 2 B16-IFNA9 Tumours (Day …
- GSM8797581 B16-IFNA9 Tumours (Day 8) mouse 3 biol rep 3 B16-IFNA9 Tumours (Day …
- GSM8797582 B16-IFNA9 Tumours (Day 8) mouse 3 biol rep 4 B16-IFNA9 Tumours (Day …
- GSE295483 Type-I interferon priming signal balances anti-bacterial and anti-tumor trained immunity in alveolar macrophages [RNA-seq] 19 samples shares interferon, immunity, type
- GSE268876 Spatially clustered type I interferon responses at injury borderzones [scRNA-Seq] 12 samples shares interferon, scrna-seq, type
- GSE217807 ARID1A suppresses R-loop mediated STING-Type I Interferon pathway activation of anti-tumor immunity 62 samples shares interferon, immunity, type
- GSE317032 Non-cytolytic viral vaccine vectors induce durable effector-memory CD8 T cell immunity by triggering type I interferon 18 samples shares interferon, immunity, type
- GSE297709 STING agonists drive recruitment and intrinsic type I interferon responses in monocytic lineage cells for optimal anti-tumor immunity 18 samples shares interferon, immunity, type
- GSE285518 Inhibition of tumor-intrinsic NAT10 enhances antitumor immunity by triggering type I interferon responses via MYC/CDK2/DNMT1 pathway. 18 samples shares interferon, immunity, type
- GSE287098 Influenza virus-induced type I interferons disrupt alveolar epithelial repair and tight junction integrity in the developing lung 96 samples shares interferon, type
- GSE304521 SEX-DEPENDENT TYPE I INTERFERON SIGNALING EXACERBATES ALZHEIMER'S PATHOLOGY 82 samples shares interferon, type
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.